News Details

National Comprehensive Cancer Network and Multiple Myeloma Research Foundation Launch Multiple Myeloma Resource Line for Physicians

JENKINTOWN, Pa., August 8, 2005 — The National Comprehensive Cancer Network (NCCN), in collaboration with the Multiple Myeloma Research Foundation (MMRF), has launched the Multiple Myeloma Resource Line. This free service provides physicians access to NCCN expert faculty, who answer questions on specific clinical issues related to the management of multiple myeloma. Physicians can call 866-528-NCCN (6226) Monday through Friday, 9 a.m. to 5 p.m. ET or e-mail questions to MultipleMyeloma@nccn.org.

“NCCN is proud to be able to offer this new level of interaction to help support clinical decision-making and advance patient care,” said William T. McGivney, Ph.D., Chief Executive Officer of NCCN.

“With the establishment of this resource, physicians now have access to discuss treatment options with leading experts in the area of multiple myeloma,” said Kathy Giusti, Founder and Chief Executive Officer of MMRF. “We are pleased to be able to offer this unique resource in partnership with the NCCN.”

Expert guidance is available within one to two business days from members of the NCCN Multiple Myeloma Guidelines Panel: Kenneth C. Anderson, MD, Dana-Farber/Partners CancerCare; William Bensinger, MD, University of Washington, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; and Seema Singhal, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), a nonprofit alliance of 19 of the world’s leading cancer centers, is dedicated to improving the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN member institutions, NCCN develops resources that present valuable information to the numerous stakeholders throughout the health care delivery system. As the arbiter of high-quality cancer care, NCCN emphasizes the importance of and promotes continuous quality improvement, creating and publishing clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. NCCN programs include: Clinical Practice Guidelines in Oncology™, the NCCN Drugs & Biologics Compendium™, Treatment Guidelines for Patients, the Journal of the National Comprehensive Cancer Network (JNCCN), Cancer Resource Lines for Leukemia and Multiple Myeloma, educational conferences and symposia for clinicians, the Oncology Outcomes Project, the NCCN Oncology Research Program, NCCN Cancer Case Manager™, and collaborations with managed care organizations.

The NCCN member institutions are:

• City of Hope Cancer Center
• Dana-Farber/Partners CancerCare
• Duke Comprehensive Cancer Center
• Fox Chase Cancer Center
• Huntsman Cancer Institute at the University of Utah
• Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
• Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University
• The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
• Robert H. Lurie Comprehensive Cancer Center of Northwestern University
• Memorial Sloan-Kettering Cancer Center
• H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida
• Roswell Park Cancer Institute
• St. Jude Children`s Research Hospital / University of Tennessee Cancer Institute
• Stanford Hospital & Clinics
• University of Alabama at Birmingham Comprehensive Cancer Center
• UCSF Comprehensive Cancer Center
• University of Michigan Comprehensive Cancer Center
• UNMC Eppley Cancer Center at The Nebraska Medical Center
• The University of Texas M. D. Anderson Cancer Center

About the Multiple Myeloma Research Foundation

The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, a newly diagnosed multiple myeloma patient, with the unique mission of accelerating the search for a cure for multiple myeloma. Today, the MMRF is the world’s number one funder of myeloma research, a pioneer in building interdisciplinary scientific collaborations, a leader in professional and patient education, and a powerful advocate for patients living with the disease. To learn more about the MMRF, visit www.multiplemyeloma.org.

For more information or to arrange interviews, contact: